Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.37 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.37 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.37 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.37 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.37 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20149458 | 0.94 | KDM4E (0.41) | DUSP3POLBTDP1TUBB4ATUBB | |
| SCHEMBL20149459 | 0.92 | KDM4E (0.46) | DUSP3POLBTDP1TUBB4ATUBB | |
| SCHEMBL20149463 | 0.91 | POLB (0.43) | DUSP3POLBTDP1TUBB4ATUBB | |
| SCHEMBL20149428 | 0.88 | TDP1 (0.44) | POLBTDP1PTGS1PTGS2GSR | |
| SCHEMBL17056815 | 0.86 | POLB (0.38) | POLBTDP1TUBB4ATUBBTUBA3C | |
| SCHEMBL17056792 | 0.86 | CNR1 (0.39) | POLBTDP1TUBB4ATUBBTUBA3C | |
| SCHEMBL20149464 | 0.86 | CYP1A2 (0.38) | DUSP3TDP1TUBB4ATUBBTUBA3C | |
| SCHEMBL20149465 | 0.85 | KDM4E (0.41) | DUSP3POLBTUBB4ATUBBTUBA3C | |
| SCHEMBL21709203 | 0.85 | MAPK10 (0.32) | DUSP3POLBTDP1TUBB4ATUBB | |
| SCHEMBL12447618 | 0.85 | POLB (0.44) | DUSP3POLBTDP1TUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139757-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230139757-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230023388-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220173326-A1 | MELT MIXTURE FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | EML4, LAGE3, KCNN4 | DUSP3 3064/4885POLB 1355/4885TDP1 2738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.